TESTSEALABS is ready for the fight across the country against the new Coronavirus (COVID-19)

In late June 2020, due to the emergence of a new epidemic in Beijing, the prevention and control of new coronavirus in China suddenly became tense. The leaders of the central government and Beijing have reviewed the situation and formulated a meticulous anti-epidemic and investigation plan with unprecedented efforts. In order to alleviate the pressure of reagent gaps in the investigation of new crowns in various districts of Beijing, Hangzhou Testsea biotechnology co., LTD. and the Institute of Microbiology of the Chinese Academy of Sciences and soon to establish emergency team donated a jointly developed COVID-19 IgG/IgM rapid diagnostic reagent, demonstrating social responsibility!

As a national high-tech enterprise, Hangzhou Testsea biotechnology co., LTD. has been engaged in research, development, and production of IVD reagents. It attaches great importance to the epidemic and strives to win the new coronavirus prevention and control war. On February 10th, the company cooperated with the Institute of Microbiology of the Chinese Academy of Sciences to set up a special R&D project team for the detection of new coronavirus, and directly added 2 million yuan of research and development funds for the development of new products for rapid detection of COVID-19 antigen and antibody. The product passed the EU CE certification in early March 2020. In early April,TESTSEALABS and ANSO Alliance jointly donated COVID-19 IgG/IgM rapid diagnostic reagents to Thailand and Algeria.